Ceftazidime Injection, Powder, For Solution
Product Images NDC 25021-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ceftazidime (NDC 25021-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cef0f 0010 01

FDA Label Image

Cef0f 0010 02

Cef0f 0010 02
The text contains detailed information on the administration and preparation of a Pharmacy Bulk Package of ceftazidime. It includes instructions for constitution, storage conditions, dosage, and administration procedures. The package insert should be consulted for specific details on dosage and administration. It also provides information on the sodium content in the solution and mentions that the container closure is latex-free.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.